ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,448, issued on April 21, was assigned to REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Mich.). "Porous self-healing polymer matrix for... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,449, issued on April 21, was assigned to Korea Institute of Geoscience and Mineral Resources (Daejeon, South Korea). "Drug-clay mineral co... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,450, issued on April 21, was assigned to C4 THERAPEUTICS INC. (Watertown, Mass.). "C3-carbon linked glutarimide Degronimers for target pro... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,451, issued on April 21, was assigned to Novartis AG (Basel, Switzerland). "Targeted plasma protein degradation" was invented by Martin Al... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,452, issued on April 21, was assigned to Regents of the University of Minnesota (Minneapolis) and Regents of the University of California (... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,453, issued on April 21, was assigned to Industry-University Cooperation Foundation Hanyang University (Seoul, South Korea), Konkuk Univers... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,454, issued on April 21, was assigned to SAIBA AG (Pfaffikon, Switzerland). "Modified virus-like particles of CMV" was invented by Martin ... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,455, issued on April 21, was assigned to Vascular Biosciences (San Diego). "CAR peptide for improved coronavirus survival" was invented by... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,456, issued on April 21, was assigned to Utah Valley University (Orem, Utah). "Composition and method for HIP1-targeting inhibitor compoun... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,457, issued on April 21, was assigned to BLISS BIOPHARMACEUTICAL (HANGZHOU) Co. LTD. (Hangzhou, China). "Modified EGFR antibody with reduc... Read More